HealthEquity stockholders approve 2024 Equity Incentive Plan with 4.085M new shares

HEALTHEQUITY, INC.

Stockholders approved the 2024 Equity Incentive Plan; 4,085,000 shares authorized for future awards.
All ten director nominees elected; board composition unchanged.
Ratification of PricewaterhouseCoopers as independent auditor for FY2025 approved.
Non-binding advisory vote on fiscal 2024 executive compensation passed.
No further awards under the 2014 Plan; replaced by the 2024 Plan.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.